Is Welchol used for diabetes?

What is Welchol used for?

Welchol (colesevelam hydrochloride) is primarily used as a cholesterol-lowering medication, specifically to reduce low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol. It's an oral medication that belongs to the class of drugs known as bile acid sequestrants [1]. According to the manufacturer, Welchol is approved by the FDA to be used in conjunction with diet to lower LDL cholesterol in adults.

Is Welchol used off-label for diabetes?

There have been studies suggesting that Welchol may also have a potential role in managing blood sugar levels in people with type 2 diabetes [2]. The exact mechanism of how Welchol affects blood sugar is not fully understood, but it may be related to its ability to reduce glucagon levels and improve insulin sensitivity [3]. Some clinical trials have explored the use of Welchol as an add-on therapy for type 2 diabetes patients, demonstrating its potential benefits in improving glycemic control and reducing medication use [4]. While these findings are promising, it's essential to note that Welchol is not FDA-approved for the treatment of diabetes.

Can I take Welchol for diabetes?

If you're considering taking Welchol for diabetes management, it's crucial to consult your doctor or healthcare provider. They will assess your individual situation, taking into account your medical history, current treatment, and other factors. Welchol may be recommended as an off-label treatment for diabetes, but it's essential to weigh the potential benefits and risks. Your healthcare provider will help you navigate these considerations and work with you to develop a comprehensive treatment plan.

Sources:

[1] DrugPatentWatch.com. (n.d.). Welchol (colesevelam hydrochloride) Medication Information. Retrieved from https://www.drugpatentwatch.com/welchol/

[2] US FDA. (2014). Welchol (colesevelam hydrochloride) Tablets. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021933s011lb.pdf

[3] Cymbaluk, B. et al. (2017). The effects of colesevelam on glucose homeostasis in patients with type 2 diabetes mellitus: a systematic review. European Journal of Endocrinology, 177(4), R135–R145.

[4] Fonseca, V. et al. (2014). Effects of colesevelam on glycemic control and lipid profiles in patients with type 2 diabetes. Journal of Clinical Lipidology, 8(2), 142–148.